Production of nitrile and polyisoprene,
crucial ingredients in protective exam gloves, completes the
organization's efforts to onshore supply chain for crucial
PPE
HARVARD,
Ill., Aug. 6, 2024 /PRNewswire/ -- U.S. Medical
Glove Company (USMGC) — the only American manufacturer of the
machines, components, and chemicals necessary to make nitrile and
polyisoprene gloves in the United
States — announced today the acquisition of a domestic
polyisoprene chemical facility. The acquisition makes USMGC the
only end-to-end, Made-in-America manufacturer of both nitrile and
polyisoprene gloves.
Alongside the acquisition, USMGC launched an independent
division to oversee the production of raw nitrile and polyisoprene,
crucial ingredients in both surgical and medical exam gloves. The
new division is U.S. Medical Chemical Company (USMCC), which will
exclusively supply USMGC with the raw materials required to
manufacture a suite of personal protective equipment (PPE) to
fulfill contracts across the U.S. government, including agencies
such as the U.S. Army, FEMA, U.S. Customs and Border Protection,
and USPS.
"The PPE shortages prevalent through the pandemic proved how
critical American control of the supply chain was in safeguarding
American health and security," said Alex
Todoroki of USMGC. "By adding this facility to our
portfolio, USMGC has now secured the raw supplies, advanced
machinery, and 30+ production lines to manufacture 2.5 billion
nitrile and polyisoprene surgical gloves by the end of 2024. We are
incredibly proud that our entire supply chain is 100% made in
America."
At the 100,000-square-foot, 22-acre chemical plant, USMCC
manufactures 3.2M dry pounds of
polyisoprene annually, which yields 60M polyisoprene surgical gloves. These sterile
surgical gloves are highly sought after in operating rooms, surgery
theaters, and other venues across the healthcare industry for their
tactile sensitivity, puncture-resistance, and certified protection
from over 24 chemotherapy drugs. Polyisoprene also has an almost
identical chemical structure as latex, making these gloves a safe
alternative to the allergens found in latex.
In addition to the manufacturing of NBR/nitrile and
polyisoprene, the new USMCC facility also houses chemists,
engineers, and technicians who oversee advanced machine
manufacturing that includes all components of dipping lines,
stainless tanks, control panels, and stripping and layering
machines. To maintain the high-quality standards the plant achieved
for over 25 years, much of the facility's former team continue to
hold key positions at USMCC. This includes roles in Quality
Assurance, a team that rigorously tests and inspects surgical exam
gloves, which undergo final sterilizations before being packed and
shipped across America and to allies in strategic locations
abroad.
"The future is bright," said Frank
Wardlaw, Technical Support Manager at USMCC. "Americans
are waking up to realize that the reindustrialization of
America is a matter of national security. We can no longer offshore
the production of critical medical supplies like PPE to foreign
powers who are oftentimes our adversaries."
Additional details about the acquisition have not been
disclosed.
ABOUT U.S. MEDICAL CHEMICAL COMPANY
U.S. Medical Chemical Company (USMCC) is the only company that
manufactures the key chemicals used in the production of medical
gloves in the United States. In
the production of NBR/nitrile and polyisoprene, USMCC is protecting
Americans through advanced chemistry, engineering, and fabrication.
USMCC is the first end-to-end manufacturer of both polyisoprene
surgical exam and medical examination gloves, with capability at
every stage of production—from raw materials to the manufacturing
of the final product—making its entire supply chain 100% made in
America. USMCC is a division of U.S. Medical Glove Company (USMGC).
For more information, please visit: www.usmcc.us
ABOUT U.S. MEDICAL GLOVE COMPANY
U.S. Medical Glove Company (USMGC) is the world's first
end-to-end manufacturer of nitrile and polyisoprene surgical and
exam gloves, headquartered in its 1.8 million-square-foot facility
in Harvard, IL. USMGC oversees on
American soil every stage of production—from raw materials, to
machine manufacturing, to deploying AI technology in the
development of its proprietary ERP, to the distribution of the
final products. With funding and support from the Department of
Defense, Department of Health and Human Services and the
Administration for Strategic Preparedness & Response, USMGC is
able to fulfill its mission to secure the supply of gloves and
other personal protective equipment (PPE) for the United States and its allies. For more
information, please visit: www.usmg.us
Media Contact:
John Flaherty
773-799-8200
381426@email4pr.com
View original
content:https://www.prnewswire.com/news-releases/acquisition-of-polyisoprene-chemical-facility-makes-us-medical-glove-company-only-end-to-end-made-in-america-producer-of-medical-gloves-302215499.html
SOURCE U.S. Medical Glove Company